Search results
Novartis to buy radiology drug specialist Mariana for $1 billion
Reuters via AOL· 13 hours agoNovartis agreed to acquire U.S. radiopharmaceutical company Mariana Oncology for $1 billion upfront,...
Novartis to Buy Mariana Oncology, Paying $1 Billion Upfront
Bloomberg· 13 hours agoNovartis agreed to buy US biotech Mariana Oncology Inc. in a deal to strengthen its pipeline of...
Novartis to pay up to $1.75 billion for U.S. cancer-focused biotech
Market Watch· 13 hours agoPharmaceutical giant Novartis AG on Thursday said it will pay up to $1.75 billion for a U.S. biotech...
Novartis further entrenches into radiopharma with $1B Mariana buy
FierceBiotech· 14 hours agoWith much still to discover in the massive world of radiopharmaceuticals, Novartis will take a deep...
Novartis Is Tracking Well Above the Industry
GuruFocus.com via Yahoo Finance· 1 day agoNovartis AG (NYSE:NVS) is one of the largest pharmaceutical companies in the world, many of whose drugs are "gold standards" in the treatment of cancer,...
Novartis to buy Mariana Oncology in radiopharmaceutical expansion
BioPharma Dive via Yahoo Finance· 12 hours agoDive Brief: Novartis is expanding its pipeline of radiopharmaceutical drugs, announcing Thursday it...
Novartis to Buy Mariana Oncology for Up to $1.75 Billion in Boost to Radioligand Therapy Business
Morningstar· 13 hours agoBy Mauro Orru Novartis agreed to acquire U.S. biotechnology company Mariana Oncology for up to $1.75 billion, in a deal that bolsters its radioligand therapy pipeline and ...
Mather Group LLC. Acquires 1,712 Shares of Novartis AG (NYSE:NVS)
ETF DAILY NEWS· 1 day agoMather Group LLC. boosted its holdings in Novartis AG (NYSE:NVS – Free Report) by 22.1% in the fourth quarter, according to its most recent 13F filing with the Securities ...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 18 hours agoMerck & Co- $30.5bn Roche- $15.56bn (CHF 14.20bn) Johnson & Johnson- $15.09bn Novartis- $ 11.37bn AstraZeneca- $10.94bn Pfizer- $10.58bn Eli Lilly-...
Novartis pays PeptiDream $180M as radiopharma big bang continues
FierceBiotech· 3 days agoNovartis is pumping another $180 million into its radioligand plan, handing the cash to serial dealmaker PeptiDream to expand (PDF) a peptide-drug conjugate (PDC) collaboration ...
